Chinese guidelines for perioperative airway management in thoracic surgery (2020 edition)_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 ZHI Xiuyi ¹ ,  LIU Lunxu ² , Writing Committee of Chinese Guidelines for Perioperative Airway Management in Thoracic Surgery (2020 edition)

1. Department of Thoracic Surgery, Xuanwu Hospital of Capital Medical University, Beijing, 100053, P.R.China;
2. Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

ZHI Xiuyi, Email: xiuyizhi2015@163.com; LIU Lunxu, Email: lunxu_liu@aliyun.com

Keywords：

Airway management; thoracic surgery; perioperative period; clinical guideline; recommendations

DOI：

10.7507/1007-4848.202012090

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective The clinical trial evidence and expert consensus in the airway management were systematically summarized in this guideline to provide clinical guidance for healthcare professionals.Methods A total of 40 clinical questions were proposed by 32 experts, and 12 clinical questions were finally identified through the Delphi method and the PICO (patient, intervention, control, outcome) principle from 2019 to 2020. PubMed, Web of Science, Wanfang database and CNKI were searched from establishment of each database up to November, 2020. The evidence of 160 articles was graded according to GRADE method, including 18 in class A, 36 in class B, 69 in class C, and 37 in class D. Four symposiums were organized for discussion of the recommendations. Finally, 23 recommendations were made for these 12 clinical questions, among which 10 were strongly recommended and 13 were weakly recommended.Results Smoking cessation for at least 4 weeks, pulmonary function assessment and pulmonary rehabilitation exercise were recommended in the perioperative period, especially at least 1 week of pulmonary rehabilitation exercise for the patients with high risk factors. Anesthesia was maintained by inhalation or intravenous anesthesia. It was recommended to choose short acting drugs, monitor the depth of anesthesia and muscle relaxation during operation, and use protective ventilation strategy. Postoperative use of drugs and mechanical measures to prevent venous thromboembolism, the appropriate application of drainage tube, preemptive analgesia and multimodal analgesia for pain management were recommended. Inhaled corticosteroids with bronchodilators could be used in perioperative period to reduce airway hyperresponsiveness and postoperative cough.Conclusion For perioperative airway management, smoking cessation, pulmonary function assessment and pulmonary rehabilitation exercise are recommended in the perioperative period. The rational use of anesthetic drugs and protective ventilation strategy are emphasized during the operations. Postoperative pain management and cough treatment should be strengthened, and drainage tube should be used properly.

Citation： ZHI Xiuyi, LIU Lunxu, Writing Committee of Chinese Guidelines for Perioperative Airway Management in Thoracic Surgery (2020 edition). Chinese guidelines for perioperative airway management in thoracic surgery (2020 edition). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2021, 28(3): 251-262. doi: 10.7507/1007-4848.202012090 Copy

1.	中國加速康復外科專家組. 中國加速康復外科圍手術期管理專家共識(2016). 中華外科雜志, 2016, 54(6): 413-418.
2.	車國衛, 劉倫旭. 加速肺康復外科, 需要精準治療嗎? 中國肺癌雜志, 2017, 20(8): 549-554.
3.	Schmid M, Sood A, Campbell L, et al. Impact of smoking on perioperative outcomes after major surgery. Am J Surg, 2015, 210(2): 221-229.
4.	Mills E, Eyawo O, Lochhart L, et al. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med, 2011, 124(2): 144-154.e8.
5.	魏詩晴, 賴曉全, 韓穎, 等. 術前戒煙時間對術后肺部并發癥影響的 Meta 分析. 中華健康管理學雜志, 2018, 12(1): 32-37.
6.	Miller JI. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg, 1993, 105(2): 347-351.
7.	中國醫師協會胸外科醫師分會,“胸外科圍手術期肺部并發癥”研討會. 胸外科圍手術期肺部并發癥防治專家共識. 中華胸心血管外科雜志, 2009, 25(4): 217-218.
8.	Bolliger CT, Jordan P, Soler M, et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med, 1995, 151(5): 1472-1480.
9.	Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis, 1989, 139(4): 902-910.
10.	Nakahara K, Ohno K, Hashimoto J, et al. Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer. Ann Thorac Surg, 1988, 46(5): 549-552.
11.	Puente-Maestú L, Villar F, González-Casurrán G, et al. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV? and diffusing capacity of the lung for carbon monoxide < 40%. Chest, 2011, 139(6): 1430-1438.
12.	Ferguson MK, Watson S, Johnson E, et al. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg, 2014, 45(4): 660-664.
13.	Celli BR. What is the value of preoperative pulmonary function testing? Med Clin North Am, 1993, 77(2): 309-325.
14.	Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest, 1994, 105(3): 753-759.
15.	Harpole DH, Liptay MJ, DeCamp MJ, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg, 1996, 61(3): 977-982.
16.	Turner SE, Eastwood PR, Cecins NM, et al. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest, 2004, 126(3): 766-773.
17.	Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J, 2009, 34(1): 17-41.
18.	Brunelli A, Kim AW, Berger KI, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5): e166S-e190S.
19.	Bolliger CT, Wyser C, Roser H, et al. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest, 1995, 108(2): 341-348.
20.	Holden DA, Rice TW, Stelmach K, et al. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest, 1992, 102(6): 1774-1779.
21.	Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg, 1987, 44(4): 344-349.
22.	Olsen GN, Weiman DS, Bolton JWR, et al. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection. Chest, 1989, 95(2): 267-273.
23.	Walsh GL, Morice RC, Putnam JJ, et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg, 1994, 58(3): 704-711.
24.	Bayram AS, Candan T, Gebitekin C. Preoperative maximal exercise oxygen consumption test predicts postoperative pulmonary morbidity following major lung resection. Respirolog, 2007, 12(4): 505-510.
25.	Brunelli A, Belardinelli R, Refai M, et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest, 2009, 135(5): 1260-1267.
26.	Benzo R, Kelley GA, Recchi L, et al. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med, 2007, 101(8): 1790-1797.
27.	Brunelli A, Xiume F, Refai M, et al. Peak oxygen consumption measured during the stair-climbing test in lung resection candidates. Respiration, 2010, 80(3): 207-211.
28.	Boujibar F, Gillibert A, Gravier FE, et al. Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis. Thorax, 2020, 75(9): 791-797.
29.	Win T, Jackson A, Groves AM, et al. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax, 2006, 61(1): 57-60.
30.	Fennelly J, Potter L, Pompili C, et al. Performance in the shuttle walk test is associated with cardiopulmonary complications after lung resections. J Thorac Dis, 2017, 9(3): 789-795.
31.	Wang Z, Zhang J, Cheng Z, et al. Factors affecting major morbidity after video-assisted thoracic surgery for lung cancer. J Surg Res, 2014, 192(2): 628-634.
32.	Zaatar M, Stork T, Valdivia D, et al. Minimal-invasive approach reduces cardiopulmonary complications in elderly after lung cancer surgery. J Thorac Dis, 2020, 12(5): 2372-2379.
33.	鄭春輝, 陳曉美, 涂韻松. Ⅰ期非小細胞肺癌患者胸腔鏡手術后發生并發癥的相關因素研究. 現代實用醫學, 2018, 30(8): 1047-1049.
34.	徐衛華, 錢永躍, 徐忠恒, 等. 肺癌患者圍術期并發癥發生的危險因素分析. 中國血液流變學雜志, 2009, 19(1): 82-84, 111.
35.	陳從華, 明煒. 肺癌微創手術術后并發癥發生的影響因素分析. 實用心腦肺血管病雜志, 2016, 24(S1): 112-113.
36.	胡廣男. 非小細胞肺癌術后并發癥的危險因素分析和預防措施. 中國實用醫藥, 2015, 10(34): 55-56.
37.	李震宇, 張磊冰, 王俊, 等. 胸腔鏡治療老年早期肺癌圍術期心肺并發癥危險因素分析. 重慶醫學, 2016, 45(22): 3055-3056, 3059.
38.	Musallam KM, Rosendaal FR, Zaatari G, et al. Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg, 2013, 148(8): 755-762.
39.	Lin CS, Chang CC, Yeh CC, et al. Postoperative adverse outcomes in patients with asthma: A nationwide population-based cohort study. Medicine (Baltimore), 2016, 95(3): e2548.
40.	Yamakage M, Iwasaki S, Namiki A. Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease. J Anesth, 2008, 22(4): 412-428.
41.	楊柳. 吸入性糖皮質激素對氣道高反應性的應用及作用機制. 臨床與病理雜志, 2018, 38(3): 664-669.
42.	熊亮, 陶曉南. 氣道高反應性發生機制及與之相關臨床疾病. 國際呼吸雜志, 2006, 26(3): 223-225.
43.	Lin H, Lu Y, Lin L, et al. Does chronic obstructive pulmonary disease relate to poor prognosis in patients with lung cancer?: A meta-analysis. Medicine (Baltimore), 2019, 98(11): e14837.
44.	Li SJ, Zhou XD, Huang J, et al. A systematic review and meta-analysis-does chronic obstructive pulmonary disease predispose to bronchopleural fistula formation in patients undergoing lung cancer surgery? J Thorac Dis, 2016, 8(7): 1625-1638.
45.	Li S, Zhou K, Du H, et al. Body surface area is a novel predictor for surgical complications following video-assisted thoracoscopic surgery for lung adenocarcinoma: a retrospective cohort study. BMC Surg, 2017, 17(1): 69.
46.	Brunelli A. Algorithm for functional evaluation of lung resection candidates: time for reappraisal? Respiration, 2009, 78(1): 117-118.
47.	Taylor MD, LaPar DJ, Isbell JM, et al. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer. J Thorac Cardiovasc Surg, 2014, 147(2): 738-744.
48.	Gao K, Yu P, Su J, et al. Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery: A study for 342 cases. Thorac Cancer, 2015, 6(4): 443-449.
49.	Smith M, Ellis E. Is retained mucus a risk factor for the development of postoperative atelectasis and pneumonia? — Implications for the physiotherapist. Physiother Theory Pract, 2000, 16(2): 69-80.
50.	Kulnik ST, Birring SS, Hodsoll J, et al. Higher cough flow is associated with lower risk of pneumonia in acute stroke. Thorax, 2016, 71(5): 474-475.
51.	Lai Y, Wang X, Li P, et al. Preoperative peak expiratory flow (PEF) for predicting postoperative pulmonary complications after lung cancer lobectomy: a prospective study with 725 cases. J Thorac Dis, 2018, 10(7): 4293-4301.
52.	D'Journo XB, Rolain JM, Doddoli C, et al. Airways colonizations in patients undergoing lung cancer surgery. Eur J Cardiothorac Surg, 2011, 40(2): 309-319.
53.	高珂, 賴玉田, 黃健, 等. 肺癌肺葉切除患者術前存在氣道定植菌與術后肺炎的發生有相關性嗎? 中國肺癌雜志, 2017, 20(4): 239-247.
54.	Yeh DD, Fuentes E, Quraishi SA, et al. Adequate nutrition may get you home: Effect of caloric/protein deficits on the discharge destination of critically ill surgical patients. JPEN J Parenter Enteral Nutr, 2016, 40(1): 37-44.
55.	Sebio Garcia R, Yá?ez Brage MI, Giménez Moolhuyzen E, et al. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg, 2016, 23(3): 486-497.
56.	Sekine Y, Chiyo M, Iwata T, et al. Perioperative rehabilitation and physiotherapy for lung cancer patients with chronic obstructive pulmonary disease. Jpn J Thorac Cardiovasc Surg, 2005, 53(5): 237-243.
57.	Divisi D, Di Francesco C, Di Leonardo G, et al. Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease. Eur J Cardiothorac Surg, 2013, 43(2): 293-296.
58.	Licker M, Karenovics W, Diaper J, et al. Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery: A randomized controlled trial. J Thorac Oncol, 2017, 12(2): 323-333.
59.	Lai Y, Huang J, Yang M, et al. Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial. J Surg Res, 2017, 209: 30-36.
60.	賴玉田, 蘇建華, 楊梅, 等. 術前短期綜合肺康復訓練對肺癌合并輕中度慢性阻塞性肺病患者的影響: 一項前瞻性隨機對照試驗. 中國肺癌志, 2016, 19(11): 746-753.
61.	Lai Y, Su J, Qiu P, et al. Systematic short-term pulmonary rehabilitation before lung cancer lobectomy: a randomized trial. Interact Cardiovasc Thorac Surg, 2017, 25(3): 476-483.
62.	Zhou K, Lai YT, Wang Y, et al. Comprehensive pulmonary rehabilitation is an effective way for better postoperative outcomes in surgical lung cancer patients with risk factors: a propensity score-matched retrospective cohort study. Cancer Manag Res, 2020, 12: 8903-8912.
63.	Huang J, Lai Y, Zhou X, et al. Short-term high-intensity rehabilitation in radically treated lung cancer: a three-armed randomized controlled trial. J Thorac Dis, 2017, 9(7): 1919-1929.
64.	Lai Y, Wang X, Zhou K, et al. Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: a randomized trial. Ann Transl Med, 2019, 7(20): 544.
65.	Silvanus MT, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation. Anesthesiology, 2004, 100(5): 1052-1057.
66.	Liccardi G, Salzillo A, Sofia M, et al. Bronchial asthma. Curr Opin Anaesthesiol, 2012, 25(1): 30-37.
67.	中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南(2016 年版). 中華結核和呼吸雜志, 2016, 39(9): 675-697.
68.	Nojiri T, Inoue M, Yamamoto K, et al. Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery. Surg Today, 2014, 44(2): 285-290.
69.	Leiro-Fernandez V, Priegue CA, Fernandez-Villar A. Efficacy of double bronchodilation (LABA+LAMA) in patients with chronic obstructive pulmonary disease (COPD) and lung cancer. Arch Bronconeumol, 2016, 52(12): 622-623.
70.	Suzuki H, Sekine Y, Yoshida S, et al. Efficacy of perioperative administration of long-acting bronchodilator on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease. Preliminary results of a randomized control study. Surg Today, 2010, 40(10): 923-930.
71.	Takegahara K, Usuda J, Inoue T, et al. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease. Gen Thorac Cardiovasc Surg, 2017, 65(7): 388-391.
72.	Shelley RS, Thomas MO, Edwin ES. Meta-analysis: respiratory tolerance to regular β2-agonist use in patients with asthma. Ann Intern Med, 2004, 140: 802.
73.	Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol, 2011, 163(1): 29-43.
74.	Ju NY, Gao H, Huang W, et al. Therapeutic effect of inhaled budesonide (Pulmicort(R) Turbuhaler) on the inflammatory response to one-lung ventilation. Anaesthesia, 2014, 69(1): 14-23.
75.	Li W, Zhao Y, Sun Z, et al. Lung protective effects of budesonide nebulization during perioperative period of thoracolumbar fusion. J Thorac Dis, 2014, 6(12): 1800-1807.
76.	劉玉, 張梅, 袁耒, 等. 伴中、重度慢性阻塞性肺疾病行開胸手術患者圍手術期氣道管理藥物應用評價. 中國胸心血管外科臨床雜志, 2015, 22(12): 1104-1108.
77.	余祖濱, 盧瀟, 王靜思, 等. 布地奈德聯合異丙托溴銨霧化吸入對圍手術期肺癌合并中重度 COPD 患者的臨床應用研究. 臨床肺科雜志, 2019, 24(10): 1851-1854.
78.	B?lükbas S, Eberlein M, Eckhoff J, et al. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Eur J Cardiothorac Surg, 2011, 39(6): 995-1000.
79.	Baker WL, Anglade MW, Baker EL, et al. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg, 2009, 35(3): 521-527.
80.	宗川曰, 解成蘭, 李茂. 福多司坦治療全麻插管術后咳嗽及預防術后肺炎的臨床療效研究. 新疆醫科大學學報, 2019, 42(4): 525-528.
81.	高陽, 程遠大, 董碩, 等. 圍術期應用氨溴索對胸腔鏡下肺葉切除術后肺癌患者的作用. 中南大學學報(醫學版), 2014, 39(8): 849-854.
82.	Odor PM, Bampoe S, Gilhooly D, et al. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ, 2020, 368: m540.
83.	Sok M, Dragas AZ, Erzen J, et al. Sources of pathogens causing pleuropulmonary infections after lung cancer resection. Eur J Cardiothorac Surg, 2002, 22(1): 23-29.
84.	Ioanas M, Angrill J, Baldo X, et al. Bronchial bacterial colonization in patients with resectable lung carcinoma. Eur Respir J, 2002, 19(2): 326-332.
85.	Belda J, Cavalcanti M, Ferrer M, et al. Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery. Chest, 2005, 128(3): 1571-1579.
86.	Dancewicz M, Szymankiewicz M, Bella M, et al. Bronchial bacterial colonization in patients with lung cancer. Pneumonol Alergol Pol, 2009, 77(3): 242-247.
87.	Schussler O, Alifano M, Dermine H, et al. Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med, 2006, 173(10): 1161-1169.
88.	Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J, 1999, 14(5): 1015-1022.
89.	文冰亭, 趙榮生. 吸入給藥裝置的結構原理及使用. 臨床藥物治療雜志, 2008, 6(1): 41-48.
90.	中國醫學裝備協會呼吸病學專委會吸入治療與呼吸康復學組, 中國慢性阻塞性肺疾病聯盟. 穩定期慢性氣道疾病吸入裝置規范應用中國專家共識. 中華結核和呼吸雜志, 2019, 42(4): 241-253.
91.	劉祖春. 吸入療法的兩種給藥方式: 吸入劑與霧化. 家庭醫學: 下半月, 2019, 3: 56-57.
92.	馮彩霞, 王建利. 霧化吸入和氣囊劑吸入兩種方式對急性哮喘發作效果評價. 醫學信息(下旬刊), 2011, 24(1): 302.
93.	韓麗華. 霧化吸入給藥的應用現狀及臨床研究進展. 中國醫藥指南, 2019, 17(8): 19-20.
94.	李轟. 布地奈德聯合特布他林霧化吸人治療對肺葉切除術肺癌患者圍手術期肺功能的影響. 臨床合理用藥, 2019, 12(4): 52-53.
95.	成人慢性氣道疾病霧化吸入治療專家組. 成人慢性氣道疾病霧化吸入治療專家共識. 中國呼吸與危重監護雜志, 2012, 11(2): 105-110.
96.	中華醫學會臨床藥學分會《霧化吸入療法合理用藥專家共識》編寫組. 霧化吸入療法合理用藥專家共識(2019 年版). 醫藥導報, 2019, 38(2): 135-146.
97.	Vehring R, Lechuga-Ballesteros D, Joshi V, et al. Cosuspensions of microcrystals and engineered micmparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers. Langmuir, 2012, 28(42): 15015-15023.
98.	Doty A, Schroeder J, Vang K, et al. Drug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: Evidence of consistency, robustness, and reliability. AAPS PharmSciTech, 2018, 19(2): 837-844.
99.	De Backer W, De Backer J, Vos W, et al. A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 2673-2684.
100.	Lechuga-Ballesteros D, Noga B, Vehring R, et al. Novel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma. Future Med Chem, 2011, 3(13): 1703-1718.
101.	Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS ?) Society Recommendations. World J Surg, 2019, 43(2): 299-330.
102.	中華醫學會外科學分會, 中華醫學會麻醉學分會. 加速康復外科中國專家共識及路徑管理指南(2018 版). 中國實用外科雜志, 2018, 38(1): 1-20.
103.	Myles PS, Leslie K, Mcneil J, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet, 2004, 363(9423): 1757-1763.
104.	Flaishon R, Windsor A, Sigl J, et al. Recovery of consciousness after thiopental or propofol. Bispectral index and isolated forearm technique. Anesthesiology, 1997, 86(3): 613-619.
105.	Brassard CL, Lohser J, Donati F, et al. Step-by-step clinical managementof one-lung ventilation: continuing professional development. Can J Anaesth, 2014, 61: 1103-1121.
106.	Ferrando C, Mugarra A, Gutierrez A, et al. Setting individualized positive end-expiratory pressure level with a positive end-expiratory pressure decrement trial after a recruitment maneuver improves oxygenation and lung mechanics during one-lung ventilation. Anesth Analg, 2014, 118: 657-665.
107.	Xue L, Fan H, Shi W, et al. Preoperative 3-dimensional computed tomography lung simulation before video-assisted thoracoscopic anatomic segmentectomy for ground glass opacity in lung. J Thorac Dis, 2018, 10(12): 6598-6605.
108.	Zhou D, Deng XF, Liu QX, et al. Single chest tube drainage is superior to double chest tube drainage after lobectomy: a meta-analysis. J Cardiothorac Surg, 2016, 11(1): 88.
109.	Lai Y, Wang X, Zhou H, et al. Is it safe and practical to use a Foley catheter as a chest tube for lung cancer patients after lobectomy? A prospective cohort study with 441 cases. Int J Surg, 2018, 56: 215-220.
110.	Kim SS, Khalpey Z, Daugherty SL, et al. Factors in the selection and management of chest tubes after pulmonary lobectomy: results of a national survey of thoracic surgeons. Ann Thorac Surg, 2016, 101(3): 1082-1088.
111.	Zhang X, Lv D, Li M, et al. The single chest tube versus double chest tube application after pulmonary lobectomy: A systematic review and meta-analysis. J Cancer Res Ther, 2016, 12(Suppl): C309-C316.
112.	楊梅, 樊駿, 周紅霞, 等. 胸腔鏡肺癌肺葉切除術后 16 F 較 28 F 胸腔引流管應用的臨床優勢. 中國肺癌雜志, 2015, 18(8): 512-517.
113.	Apostolakis EE, Baikoussis NG. Single or double drain after lung resections? Eur J Cardiothorac Surg, 2009, 36(2): 424.
114.	Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS?) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg, 2019, 55(1): 91-115.
115.	Coughlin SM, Emmerton-Coughlin HM, Malthaner R. Management of chest tubes after pulmonary resection: a systematic review and meta-analysis. Can J Surg, 2012, 55: 264-270.
116.	Deng B, Tan QY, Zhao YP, et al. Suction or non-suction to the underwater seal drains following pulmonary operation: meta-analysis of randomised controlled trials. Eur J Cardiothorac Surg, 2010, 38: 210-215.
117.	Gao S, Zhang Z, Aragón J, et al. The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy. J Thorac Dis, 2017, 9: 3255-3264.
118.	Qiu T, Shen Y, Wang MZ, et al. External suction versus water seal after selective pulmonary resection for lung neoplasm: a systematic review. PLoS One, 2013, 8: e68087.
119.	Zhang TX, Zhang Y, Liu ZD, et al. The volume threshold of 300 versus 100 ml/day for chest tube removal after pulmonary lobectomy: a meta-analysis. Interact Cardiovasc Thorac Surg, 2018, 27(5): 695-702.
120.	Zhou J, Lyu M, Chen N, et al. Digital chest drainage is better than traditional chest drainage following pulmonary surgery: a meta-analysis. Eur J Cardiothorac Surg, 2018, 54(4): 635-643.
121.	俞文峰, 潘亮, 張潔萍, 等. 新型無水胸腔負壓引流裝置在胸外科術后患者中的應用研究. 中國肺癌雜志, 2020, 23(6): 509-513.
122.	慕騰, 姜冠潮, 李曉, 等. 胸腔鏡肺切除術后持續咳嗽的多因素分析. 中國微創外科雜志, 2017, 17(7): 577-580.
123.	Xie MR, Zhu YF, Zhou MQ, et al. Analysis of factors related to chronic cough after lung cancer surgery. Thorac Cancer, 2019, 10(4): 898-903.
124.	鄧城慶, 朱曉雷. 胸腔鏡肺葉切除術后咳嗽的研究進展. 中國微創外科雜志, 2020, 20(4): 354-357.
125.	Gao YH, Guan WJ, Xu G, et al. Validation of the mandarin Chinese version of the Leicester Cough Questionnaire in bronchiectasis. Int J Tuberc Lung Dis, 2014, 18(12): 1431-1437.
126.	林嶸嘉, 車國衛, 徐志華, 等. 中文版萊斯特咳嗽問卷的改良及驗證. 中國肺癌雜志, 2017, 20(7): 468-472.
127.	Sawada S, Suehisa H, Yamashita M. Inhalation of corticosteroid and β-agonist for persistent cough following pulmonary resection. Gen Thorac Cardiovasc Surg, 2012, 60(5): 285-288.
128.	Miyamoto H, Sakao Y, Sakuraba M, et al. Usefulness of suplatast tosilate for chronic cough following lung cancer surgery. Gen Thorac Cardiovasc Surg, 2009, 57(9): 463-466.
129.	Sawabata N, Maeda H, Takeda S, et al. Persistent cough following pulmonary resection: observational and empiric study of possible causes. Ann Thorac Surg, 2005, 79(1): 289-293.
130.	Bao W, Chen Q, Lin Y, et al. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma. Respirology, 2013, 18 Suppl 3: 53-61.
131.	Tagaya E, Kondo M, Kirishi S, et al. Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma. J Asthma, 2015, 52(5): 512-518.
132.	王成碩, 程雷, 劉爭, 等. 耳鼻咽喉頭頸外科圍術期氣道管理專家共識. 中國耳鼻咽喉頭頸外科, 2019, 26(9): 463-471.
133.	Kol E, Erdogan A, Karsl? B. Nature and intensity of the pain following thoracotomy. Int J Nurs Pract, 2012, 18(1): 84-90.
134.	Refai M, Brunelli A, Salati M, et al. The impact of chest tube removal on pain and pulmonary function after pulmonary resection. Eur J Cardiothorac Surg, 2012, 41(4): 820-822.
135.	Chou R, Gordon DB, Leon-Casasola OA, et al. Management of postoperative pain: A clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain, 2016, 17(2): 131-157.
136.	Ong CK, Seymour RA, Lirk P, et al. Combining paracetamol (acetaminophen) with nonsteroidal anti inflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg, 2010, 110(4): 1170-1179.
137.	Keenan DJ, Cave K, Langdon L, et al. Comparative trial of rectal indomethacin and cryoanalgesia for control of early postthoracotomy pain. Br Med J (Clin Res Ed), 1983, 287(6402): 1335-1337.
138.	Pavy T, Medley C, Murphy DF. Effect of indomethacin on pain relief after thoracotomy. Br J Anaesth, 1990, 65(5): 624-627.
139.	Rhodes M, Conacher I, Morritt G, et al. Nonsteroidal antiinflammatory drugs for postthoracotomy pain. A prospective controlled trial after lateral thoracotomy. J Thorac Cardiovasc Surg, 1992, 103(1): 17-20.
140.	Barak M, Ziser A, Katz Y. Thoracic epidural local anesthetics are ineffective in alleviating post-thoracotomy ipsilateral shoulder pain. J Cardiothorac Vasc Anesth, 2004, 18(4): 458-460.
141.	Burgess FW, Anderson DM, Colonna D, et al. Ipsilateral shoulder pain following thoracic surgery. Anesthesiology, 1993, 78(2): 365-368.
142.	Cook TM, Riley RH. Analgesia following thoracotomy: a survey of Australian practice. Anaesth Intensive Care, 1997, 25(5): 520-524.
143.	Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth, 2005, 94(4): 505-513.
144.	Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand, 2000, 44(10): 1191-1203.
145.	徐建國. 成人手術后疼痛處理專家共識. 臨床麻醉學雜志, 2017, 33(9): 911-917.
146.	李躍, 宮立群, 徐鋒, 等. 羅哌卡因肋間神經阻滯對肺癌患者胸腔鏡術后鎮痛效果的影響. 中國腫瘤臨床, 2017, 44(12): 605-607.
147.	Brunelli A. Deep vein thrombosis/pulmonary embolism: prophylaxis, diagnosis, and management. Thorac Surg Clin, 2012, 22(1): 25-28.
148.	Dentali F, Malato A, Ageno W, et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg, 2008, 135(3): 705-706.
149.	Hicks LK, Cheung MC, Ding K, et al. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer, 2009, 115(23): 5516-5525.
150.	De Martino RR, Goodney PP, Spangler EL, et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg, 2012, 55(4): 1035-1040.e4.
151.	Rollins KE, Peters CJ, Safranek PM, et al. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery. Eur J Surg Oncol, 2011, 37(12): 1072-1077.
152.	Christensen TD, Vad H, Pedersen S, et al. Venous thromboembolism in patients undergoing operations for lung cancer: a systematic review. Ann Thorac Surg, 2014, 97(2): 394-400.
153.	Di Nisio M, Peinemann F, Porreca E, et al. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. Cochrane Database Syst Rev, 2015, 19(6): CD009658.
154.	宋春鳳, 李輝, 田博, 等. 胸外科術后靜脈血栓栓塞癥發生情況的單中心前瞻性隊列研究. 中華外科雜志, 2018, 56(4): 284-288.
155.	Hachey KJ, Hewes PD, Porter LP, et al. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer. J Thorac Cardiovasc Surg, 2016, 151(1): 37-44.
156.	Hachey KJ, Sterbling H, Choi DS, et al. Prevention of postoperative venous thromboembolism in thoracic surgical patients: Implementation and evaluation of a caprini risk assessment protocol. J Am Coll Surg, 2016, 222(6): 1019-1027.
157.	Caprini JA. Individual risk assessment is the best strategy for thromboembolic prophylaxis. Dis Mon, 2010, 56(10): 552-559.
158.	Kierkegaard A, Norgren L, Olsson CG, et al. Incidence of deep vein thrombosis in bedridden non-surgical patients. Acta Med Scand, 1987, 222(5): 409-414.
159.	Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2012, 141(2 Suppl): e227S-e277S.
160.	Gee E. The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89). Br J Haematol, 2019, 186(5): 792-793.

1. 中國加速康復外科專家組. 中國加速康復外科圍手術期管理專家共識(2016). 中華外科雜志, 2016, 54(6): 413-418.
2. 車國衛, 劉倫旭. 加速肺康復外科, 需要精準治療嗎? 中國肺癌雜志, 2017, 20(8): 549-554.
3. Schmid M, Sood A, Campbell L, et al. Impact of smoking on perioperative outcomes after major surgery. Am J Surg, 2015, 210(2): 221-229.
4. Mills E, Eyawo O, Lochhart L, et al. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med, 2011, 124(2): 144-154.e8.
5. 魏詩晴, 賴曉全, 韓穎, 等. 術前戒煙時間對術后肺部并發癥影響的 Meta 分析. 中華健康管理學雜志, 2018, 12(1): 32-37.
6. Miller JI. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg, 1993, 105(2): 347-351.
7. 中國醫師協會胸外科醫師分會,“胸外科圍手術期肺部并發癥”研討會. 胸外科圍手術期肺部并發癥防治專家共識. 中華胸心血管外科雜志, 2009, 25(4): 217-218.
8. Bolliger CT, Jordan P, Soler M, et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med, 1995, 151(5): 1472-1480.
9. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis, 1989, 139(4): 902-910.
10. Nakahara K, Ohno K, Hashimoto J, et al. Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer. Ann Thorac Surg, 1988, 46(5): 549-552.
11. Puente-Maestú L, Villar F, González-Casurrán G, et al. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV? and diffusing capacity of the lung for carbon monoxide < 40%. Chest, 2011, 139(6): 1430-1438.
12. Ferguson MK, Watson S, Johnson E, et al. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg, 2014, 45(4): 660-664.
13. Celli BR. What is the value of preoperative pulmonary function testing? Med Clin North Am, 1993, 77(2): 309-325.
14. Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest, 1994, 105(3): 753-759.
15. Harpole DH, Liptay MJ, DeCamp MJ, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg, 1996, 61(3): 977-982.
16. Turner SE, Eastwood PR, Cecins NM, et al. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest, 2004, 126(3): 766-773.
17. Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J, 2009, 34(1): 17-41.
18. Brunelli A, Kim AW, Berger KI, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2013, 143(5): e166S-e190S.
19. Bolliger CT, Wyser C, Roser H, et al. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest, 1995, 108(2): 341-348.
20. Holden DA, Rice TW, Stelmach K, et al. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest, 1992, 102(6): 1774-1779.
21. Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg, 1987, 44(4): 344-349.
22. Olsen GN, Weiman DS, Bolton JWR, et al. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection. Chest, 1989, 95(2): 267-273.
23. Walsh GL, Morice RC, Putnam JJ, et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg, 1994, 58(3): 704-711.
24. Bayram AS, Candan T, Gebitekin C. Preoperative maximal exercise oxygen consumption test predicts postoperative pulmonary morbidity following major lung resection. Respirolog, 2007, 12(4): 505-510.
25. Brunelli A, Belardinelli R, Refai M, et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest, 2009, 135(5): 1260-1267.
26. Benzo R, Kelley GA, Recchi L, et al. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med, 2007, 101(8): 1790-1797.
27. Brunelli A, Xiume F, Refai M, et al. Peak oxygen consumption measured during the stair-climbing test in lung resection candidates. Respiration, 2010, 80(3): 207-211.
28. Boujibar F, Gillibert A, Gravier FE, et al. Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis. Thorax, 2020, 75(9): 791-797.
29. Win T, Jackson A, Groves AM, et al. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax, 2006, 61(1): 57-60.
30. Fennelly J, Potter L, Pompili C, et al. Performance in the shuttle walk test is associated with cardiopulmonary complications after lung resections. J Thorac Dis, 2017, 9(3): 789-795.
31. Wang Z, Zhang J, Cheng Z, et al. Factors affecting major morbidity after video-assisted thoracic surgery for lung cancer. J Surg Res, 2014, 192(2): 628-634.
32. Zaatar M, Stork T, Valdivia D, et al. Minimal-invasive approach reduces cardiopulmonary complications in elderly after lung cancer surgery. J Thorac Dis, 2020, 12(5): 2372-2379.
33. 鄭春輝, 陳曉美, 涂韻松. Ⅰ期非小細胞肺癌患者胸腔鏡手術后發生并發癥的相關因素研究. 現代實用醫學, 2018, 30(8): 1047-1049.
34. 徐衛華, 錢永躍, 徐忠恒, 等. 肺癌患者圍術期并發癥發生的危險因素分析. 中國血液流變學雜志, 2009, 19(1): 82-84, 111.
35. 陳從華, 明煒. 肺癌微創手術術后并發癥發生的影響因素分析. 實用心腦肺血管病雜志, 2016, 24(S1): 112-113.
36. 胡廣男. 非小細胞肺癌術后并發癥的危險因素分析和預防措施. 中國實用醫藥, 2015, 10(34): 55-56.
37. 李震宇, 張磊冰, 王俊, 等. 胸腔鏡治療老年早期肺癌圍術期心肺并發癥危險因素分析. 重慶醫學, 2016, 45(22): 3055-3056, 3059.
38. Musallam KM, Rosendaal FR, Zaatari G, et al. Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg, 2013, 148(8): 755-762.
39. Lin CS, Chang CC, Yeh CC, et al. Postoperative adverse outcomes in patients with asthma: A nationwide population-based cohort study. Medicine (Baltimore), 2016, 95(3): e2548.
40. Yamakage M, Iwasaki S, Namiki A. Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease. J Anesth, 2008, 22(4): 412-428.
41. 楊柳. 吸入性糖皮質激素對氣道高反應性的應用及作用機制. 臨床與病理雜志, 2018, 38(3): 664-669.
42. 熊亮, 陶曉南. 氣道高反應性發生機制及與之相關臨床疾病. 國際呼吸雜志, 2006, 26(3): 223-225.
43. Lin H, Lu Y, Lin L, et al. Does chronic obstructive pulmonary disease relate to poor prognosis in patients with lung cancer?: A meta-analysis. Medicine (Baltimore), 2019, 98(11): e14837.
44. Li SJ, Zhou XD, Huang J, et al. A systematic review and meta-analysis-does chronic obstructive pulmonary disease predispose to bronchopleural fistula formation in patients undergoing lung cancer surgery? J Thorac Dis, 2016, 8(7): 1625-1638.
45. Li S, Zhou K, Du H, et al. Body surface area is a novel predictor for surgical complications following video-assisted thoracoscopic surgery for lung adenocarcinoma: a retrospective cohort study. BMC Surg, 2017, 17(1): 69.
46. Brunelli A. Algorithm for functional evaluation of lung resection candidates: time for reappraisal? Respiration, 2009, 78(1): 117-118.
47. Taylor MD, LaPar DJ, Isbell JM, et al. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer. J Thorac Cardiovasc Surg, 2014, 147(2): 738-744.
48. Gao K, Yu P, Su J, et al. Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery: A study for 342 cases. Thorac Cancer, 2015, 6(4): 443-449.
49. Smith M, Ellis E. Is retained mucus a risk factor for the development of postoperative atelectasis and pneumonia? — Implications for the physiotherapist. Physiother Theory Pract, 2000, 16(2): 69-80.
50. Kulnik ST, Birring SS, Hodsoll J, et al. Higher cough flow is associated with lower risk of pneumonia in acute stroke. Thorax, 2016, 71(5): 474-475.
51. Lai Y, Wang X, Li P, et al. Preoperative peak expiratory flow (PEF) for predicting postoperative pulmonary complications after lung cancer lobectomy: a prospective study with 725 cases. J Thorac Dis, 2018, 10(7): 4293-4301.
52. D'Journo XB, Rolain JM, Doddoli C, et al. Airways colonizations in patients undergoing lung cancer surgery. Eur J Cardiothorac Surg, 2011, 40(2): 309-319.
53. 高珂, 賴玉田, 黃健, 等. 肺癌肺葉切除患者術前存在氣道定植菌與術后肺炎的發生有相關性嗎? 中國肺癌雜志, 2017, 20(4): 239-247.
54. Yeh DD, Fuentes E, Quraishi SA, et al. Adequate nutrition may get you home: Effect of caloric/protein deficits on the discharge destination of critically ill surgical patients. JPEN J Parenter Enteral Nutr, 2016, 40(1): 37-44.
55. Sebio Garcia R, Yá?ez Brage MI, Giménez Moolhuyzen E, et al. Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg, 2016, 23(3): 486-497.
56. Sekine Y, Chiyo M, Iwata T, et al. Perioperative rehabilitation and physiotherapy for lung cancer patients with chronic obstructive pulmonary disease. Jpn J Thorac Cardiovasc Surg, 2005, 53(5): 237-243.
57. Divisi D, Di Francesco C, Di Leonardo G, et al. Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary disease. Eur J Cardiothorac Surg, 2013, 43(2): 293-296.
58. Licker M, Karenovics W, Diaper J, et al. Short-term preoperative high-intensity interval training in patients awaiting lung cancer surgery: A randomized controlled trial. J Thorac Oncol, 2017, 12(2): 323-333.
59. Lai Y, Huang J, Yang M, et al. Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial. J Surg Res, 2017, 209: 30-36.
60. 賴玉田, 蘇建華, 楊梅, 等. 術前短期綜合肺康復訓練對肺癌合并輕中度慢性阻塞性肺病患者的影響: 一項前瞻性隨機對照試驗. 中國肺癌志, 2016, 19(11): 746-753.
61. Lai Y, Su J, Qiu P, et al. Systematic short-term pulmonary rehabilitation before lung cancer lobectomy: a randomized trial. Interact Cardiovasc Thorac Surg, 2017, 25(3): 476-483.
62. Zhou K, Lai YT, Wang Y, et al. Comprehensive pulmonary rehabilitation is an effective way for better postoperative outcomes in surgical lung cancer patients with risk factors: a propensity score-matched retrospective cohort study. Cancer Manag Res, 2020, 12: 8903-8912.
63. Huang J, Lai Y, Zhou X, et al. Short-term high-intensity rehabilitation in radically treated lung cancer: a three-armed randomized controlled trial. J Thorac Dis, 2017, 9(7): 1919-1929.
64. Lai Y, Wang X, Zhou K, et al. Impact of one-week preoperative physical training on clinical outcomes of surgical lung cancer patients with limited lung function: a randomized trial. Ann Transl Med, 2019, 7(20): 544.
65. Silvanus MT, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation. Anesthesiology, 2004, 100(5): 1052-1057.
66. Liccardi G, Salzillo A, Sofia M, et al. Bronchial asthma. Curr Opin Anaesthesiol, 2012, 25(1): 30-37.
67. 中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南(2016 年版). 中華結核和呼吸雜志, 2016, 39(9): 675-697.
68. Nojiri T, Inoue M, Yamamoto K, et al. Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery. Surg Today, 2014, 44(2): 285-290.
69. Leiro-Fernandez V, Priegue CA, Fernandez-Villar A. Efficacy of double bronchodilation (LABA+LAMA) in patients with chronic obstructive pulmonary disease (COPD) and lung cancer. Arch Bronconeumol, 2016, 52(12): 622-623.
70. Suzuki H, Sekine Y, Yoshida S, et al. Efficacy of perioperative administration of long-acting bronchodilator on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease. Preliminary results of a randomized control study. Surg Today, 2010, 40(10): 923-930.
71. Takegahara K, Usuda J, Inoue T, et al. Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease. Gen Thorac Cardiovasc Surg, 2017, 65(7): 388-391.
72. Shelley RS, Thomas MO, Edwin ES. Meta-analysis: respiratory tolerance to regular β2-agonist use in patients with asthma. Ann Intern Med, 2004, 140: 802.
73. Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol, 2011, 163(1): 29-43.
74. Ju NY, Gao H, Huang W, et al. Therapeutic effect of inhaled budesonide (Pulmicort(R) Turbuhaler) on the inflammatory response to one-lung ventilation. Anaesthesia, 2014, 69(1): 14-23.
75. Li W, Zhao Y, Sun Z, et al. Lung protective effects of budesonide nebulization during perioperative period of thoracolumbar fusion. J Thorac Dis, 2014, 6(12): 1800-1807.
76. 劉玉, 張梅, 袁耒, 等. 伴中、重度慢性阻塞性肺疾病行開胸手術患者圍手術期氣道管理藥物應用評價. 中國胸心血管外科臨床雜志, 2015, 22(12): 1104-1108.
77. 余祖濱, 盧瀟, 王靜思, 等. 布地奈德聯合異丙托溴銨霧化吸入對圍手術期肺癌合并中重度 COPD 患者的臨床應用研究. 臨床肺科雜志, 2019, 24(10): 1851-1854.
78. B?lükbas S, Eberlein M, Eckhoff J, et al. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Eur J Cardiothorac Surg, 2011, 39(6): 995-1000.
79. Baker WL, Anglade MW, Baker EL, et al. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg, 2009, 35(3): 521-527.
80. 宗川曰, 解成蘭, 李茂. 福多司坦治療全麻插管術后咳嗽及預防術后肺炎的臨床療效研究. 新疆醫科大學學報, 2019, 42(4): 525-528.
81. 高陽, 程遠大, 董碩, 等. 圍術期應用氨溴索對胸腔鏡下肺葉切除術后肺癌患者的作用. 中南大學學報(醫學版), 2014, 39(8): 849-854.
82. Odor PM, Bampoe S, Gilhooly D, et al. Perioperative interventions for prevention of postoperative pulmonary complications: systematic review and meta-analysis. BMJ, 2020, 368: m540.
83. Sok M, Dragas AZ, Erzen J, et al. Sources of pathogens causing pleuropulmonary infections after lung cancer resection. Eur J Cardiothorac Surg, 2002, 22(1): 23-29.
84. Ioanas M, Angrill J, Baldo X, et al. Bronchial bacterial colonization in patients with resectable lung carcinoma. Eur Respir J, 2002, 19(2): 326-332.
85. Belda J, Cavalcanti M, Ferrer M, et al. Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery. Chest, 2005, 128(3): 1571-1579.
86. Dancewicz M, Szymankiewicz M, Bella M, et al. Bronchial bacterial colonization in patients with lung cancer. Pneumonol Alergol Pol, 2009, 77(3): 242-247.
87. Schussler O, Alifano M, Dermine H, et al. Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med, 2006, 173(10): 1161-1169.
88. Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J, 1999, 14(5): 1015-1022.
89. 文冰亭, 趙榮生. 吸入給藥裝置的結構原理及使用. 臨床藥物治療雜志, 2008, 6(1): 41-48.
90. 中國醫學裝備協會呼吸病學專委會吸入治療與呼吸康復學組, 中國慢性阻塞性肺疾病聯盟. 穩定期慢性氣道疾病吸入裝置規范應用中國專家共識. 中華結核和呼吸雜志, 2019, 42(4): 241-253.
91. 劉祖春. 吸入療法的兩種給藥方式: 吸入劑與霧化. 家庭醫學: 下半月, 2019, 3: 56-57.
92. 馮彩霞, 王建利. 霧化吸入和氣囊劑吸入兩種方式對急性哮喘發作效果評價. 醫學信息(下旬刊), 2011, 24(1): 302.
93. 韓麗華. 霧化吸入給藥的應用現狀及臨床研究進展. 中國醫藥指南, 2019, 17(8): 19-20.
94. 李轟. 布地奈德聯合特布他林霧化吸人治療對肺葉切除術肺癌患者圍手術期肺功能的影響. 臨床合理用藥, 2019, 12(4): 52-53.
95. 成人慢性氣道疾病霧化吸入治療專家組. 成人慢性氣道疾病霧化吸入治療專家共識. 中國呼吸與危重監護雜志, 2012, 11(2): 105-110.
96. 中華醫學會臨床藥學分會《霧化吸入療法合理用藥專家共識》編寫組. 霧化吸入療法合理用藥專家共識(2019 年版). 醫藥導報, 2019, 38(2): 135-146.
97. Vehring R, Lechuga-Ballesteros D, Joshi V, et al. Cosuspensions of microcrystals and engineered micmparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers. Langmuir, 2012, 28(42): 15015-15023.
98. Doty A, Schroeder J, Vang K, et al. Drug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: Evidence of consistency, robustness, and reliability. AAPS PharmSciTech, 2018, 19(2): 837-844.
99. De Backer W, De Backer J, Vos W, et al. A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD. Int J Chron Obstruct Pulmon Dis, 2018, 13: 2673-2684.
100. Lechuga-Ballesteros D, Noga B, Vehring R, et al. Novel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma. Future Med Chem, 2011, 3(13): 1703-1718.
101. Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS ?) Society Recommendations. World J Surg, 2019, 43(2): 299-330.
102. 中華醫學會外科學分會, 中華醫學會麻醉學分會. 加速康復外科中國專家共識及路徑管理指南(2018 版). 中國實用外科雜志, 2018, 38(1): 1-20.
103. Myles PS, Leslie K, Mcneil J, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet, 2004, 363(9423): 1757-1763.
104. Flaishon R, Windsor A, Sigl J, et al. Recovery of consciousness after thiopental or propofol. Bispectral index and isolated forearm technique. Anesthesiology, 1997, 86(3): 613-619.
105. Brassard CL, Lohser J, Donati F, et al. Step-by-step clinical managementof one-lung ventilation: continuing professional development. Can J Anaesth, 2014, 61: 1103-1121.
106. Ferrando C, Mugarra A, Gutierrez A, et al. Setting individualized positive end-expiratory pressure level with a positive end-expiratory pressure decrement trial after a recruitment maneuver improves oxygenation and lung mechanics during one-lung ventilation. Anesth Analg, 2014, 118: 657-665.
107. Xue L, Fan H, Shi W, et al. Preoperative 3-dimensional computed tomography lung simulation before video-assisted thoracoscopic anatomic segmentectomy for ground glass opacity in lung. J Thorac Dis, 2018, 10(12): 6598-6605.
108. Zhou D, Deng XF, Liu QX, et al. Single chest tube drainage is superior to double chest tube drainage after lobectomy: a meta-analysis. J Cardiothorac Surg, 2016, 11(1): 88.
109. Lai Y, Wang X, Zhou H, et al. Is it safe and practical to use a Foley catheter as a chest tube for lung cancer patients after lobectomy? A prospective cohort study with 441 cases. Int J Surg, 2018, 56: 215-220.
110. Kim SS, Khalpey Z, Daugherty SL, et al. Factors in the selection and management of chest tubes after pulmonary lobectomy: results of a national survey of thoracic surgeons. Ann Thorac Surg, 2016, 101(3): 1082-1088.
111. Zhang X, Lv D, Li M, et al. The single chest tube versus double chest tube application after pulmonary lobectomy: A systematic review and meta-analysis. J Cancer Res Ther, 2016, 12(Suppl): C309-C316.
112. 楊梅, 樊駿, 周紅霞, 等. 胸腔鏡肺癌肺葉切除術后 16 F 較 28 F 胸腔引流管應用的臨床優勢. 中國肺癌雜志, 2015, 18(8): 512-517.
113. Apostolakis EE, Baikoussis NG. Single or double drain after lung resections? Eur J Cardiothorac Surg, 2009, 36(2): 424.
114. Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS?) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg, 2019, 55(1): 91-115.
115. Coughlin SM, Emmerton-Coughlin HM, Malthaner R. Management of chest tubes after pulmonary resection: a systematic review and meta-analysis. Can J Surg, 2012, 55: 264-270.
116. Deng B, Tan QY, Zhao YP, et al. Suction or non-suction to the underwater seal drains following pulmonary operation: meta-analysis of randomised controlled trials. Eur J Cardiothorac Surg, 2010, 38: 210-215.
117. Gao S, Zhang Z, Aragón J, et al. The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy. J Thorac Dis, 2017, 9: 3255-3264.
118. Qiu T, Shen Y, Wang MZ, et al. External suction versus water seal after selective pulmonary resection for lung neoplasm: a systematic review. PLoS One, 2013, 8: e68087.
119. Zhang TX, Zhang Y, Liu ZD, et al. The volume threshold of 300 versus 100 ml/day for chest tube removal after pulmonary lobectomy: a meta-analysis. Interact Cardiovasc Thorac Surg, 2018, 27(5): 695-702.
120. Zhou J, Lyu M, Chen N, et al. Digital chest drainage is better than traditional chest drainage following pulmonary surgery: a meta-analysis. Eur J Cardiothorac Surg, 2018, 54(4): 635-643.
121. 俞文峰, 潘亮, 張潔萍, 等. 新型無水胸腔負壓引流裝置在胸外科術后患者中的應用研究. 中國肺癌雜志, 2020, 23(6): 509-513.
122. 慕騰, 姜冠潮, 李曉, 等. 胸腔鏡肺切除術后持續咳嗽的多因素分析. 中國微創外科雜志, 2017, 17(7): 577-580.
123. Xie MR, Zhu YF, Zhou MQ, et al. Analysis of factors related to chronic cough after lung cancer surgery. Thorac Cancer, 2019, 10(4): 898-903.
124. 鄧城慶, 朱曉雷. 胸腔鏡肺葉切除術后咳嗽的研究進展. 中國微創外科雜志, 2020, 20(4): 354-357.
125. Gao YH, Guan WJ, Xu G, et al. Validation of the mandarin Chinese version of the Leicester Cough Questionnaire in bronchiectasis. Int J Tuberc Lung Dis, 2014, 18(12): 1431-1437.
126. 林嶸嘉, 車國衛, 徐志華, 等. 中文版萊斯特咳嗽問卷的改良及驗證. 中國肺癌雜志, 2017, 20(7): 468-472.
127. Sawada S, Suehisa H, Yamashita M. Inhalation of corticosteroid and β-agonist for persistent cough following pulmonary resection. Gen Thorac Cardiovasc Surg, 2012, 60(5): 285-288.
128. Miyamoto H, Sakao Y, Sakuraba M, et al. Usefulness of suplatast tosilate for chronic cough following lung cancer surgery. Gen Thorac Cardiovasc Surg, 2009, 57(9): 463-466.
129. Sawabata N, Maeda H, Takeda S, et al. Persistent cough following pulmonary resection: observational and empiric study of possible causes. Ann Thorac Surg, 2005, 79(1): 289-293.
130. Bao W, Chen Q, Lin Y, et al. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma. Respirology, 2013, 18 Suppl 3: 53-61.
131. Tagaya E, Kondo M, Kirishi S, et al. Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma. J Asthma, 2015, 52(5): 512-518.
132. 王成碩, 程雷, 劉爭, 等. 耳鼻咽喉頭頸外科圍術期氣道管理專家共識. 中國耳鼻咽喉頭頸外科, 2019, 26(9): 463-471.
133. Kol E, Erdogan A, Karsl? B. Nature and intensity of the pain following thoracotomy. Int J Nurs Pract, 2012, 18(1): 84-90.
134. Refai M, Brunelli A, Salati M, et al. The impact of chest tube removal on pain and pulmonary function after pulmonary resection. Eur J Cardiothorac Surg, 2012, 41(4): 820-822.
135. Chou R, Gordon DB, Leon-Casasola OA, et al. Management of postoperative pain: A clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain, 2016, 17(2): 131-157.
136. Ong CK, Seymour RA, Lirk P, et al. Combining paracetamol (acetaminophen) with nonsteroidal anti inflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg, 2010, 110(4): 1170-1179.
137. Keenan DJ, Cave K, Langdon L, et al. Comparative trial of rectal indomethacin and cryoanalgesia for control of early postthoracotomy pain. Br Med J (Clin Res Ed), 1983, 287(6402): 1335-1337.
138. Pavy T, Medley C, Murphy DF. Effect of indomethacin on pain relief after thoracotomy. Br J Anaesth, 1990, 65(5): 624-627.
139. Rhodes M, Conacher I, Morritt G, et al. Nonsteroidal antiinflammatory drugs for postthoracotomy pain. A prospective controlled trial after lateral thoracotomy. J Thorac Cardiovasc Surg, 1992, 103(1): 17-20.
140. Barak M, Ziser A, Katz Y. Thoracic epidural local anesthetics are ineffective in alleviating post-thoracotomy ipsilateral shoulder pain. J Cardiothorac Vasc Anesth, 2004, 18(4): 458-460.
141. Burgess FW, Anderson DM, Colonna D, et al. Ipsilateral shoulder pain following thoracic surgery. Anesthesiology, 1993, 78(2): 365-368.
142. Cook TM, Riley RH. Analgesia following thoracotomy: a survey of Australian practice. Anaesth Intensive Care, 1997, 25(5): 520-524.
143. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth, 2005, 94(4): 505-513.
144. Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand, 2000, 44(10): 1191-1203.
145. 徐建國. 成人手術后疼痛處理專家共識. 臨床麻醉學雜志, 2017, 33(9): 911-917.
146. 李躍, 宮立群, 徐鋒, 等. 羅哌卡因肋間神經阻滯對肺癌患者胸腔鏡術后鎮痛效果的影響. 中國腫瘤臨床, 2017, 44(12): 605-607.
147. Brunelli A. Deep vein thrombosis/pulmonary embolism: prophylaxis, diagnosis, and management. Thorac Surg Clin, 2012, 22(1): 25-28.
148. Dentali F, Malato A, Ageno W, et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg, 2008, 135(3): 705-706.
149. Hicks LK, Cheung MC, Ding K, et al. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer, 2009, 115(23): 5516-5525.
150. De Martino RR, Goodney PP, Spangler EL, et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg, 2012, 55(4): 1035-1040.e4.
151. Rollins KE, Peters CJ, Safranek PM, et al. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery. Eur J Surg Oncol, 2011, 37(12): 1072-1077.
152. Christensen TD, Vad H, Pedersen S, et al. Venous thromboembolism in patients undergoing operations for lung cancer: a systematic review. Ann Thorac Surg, 2014, 97(2): 394-400.
153. Di Nisio M, Peinemann F, Porreca E, et al. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. Cochrane Database Syst Rev, 2015, 19(6): CD009658.
154. 宋春鳳, 李輝, 田博, 等. 胸外科術后靜脈血栓栓塞癥發生情況的單中心前瞻性隊列研究. 中華外科雜志, 2018, 56(4): 284-288.
155. Hachey KJ, Hewes PD, Porter LP, et al. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer. J Thorac Cardiovasc Surg, 2016, 151(1): 37-44.
156. Hachey KJ, Sterbling H, Choi DS, et al. Prevention of postoperative venous thromboembolism in thoracic surgical patients: Implementation and evaluation of a caprini risk assessment protocol. J Am Coll Surg, 2016, 222(6): 1019-1027.
157. Caprini JA. Individual risk assessment is the best strategy for thromboembolic prophylaxis. Dis Mon, 2010, 56(10): 552-559.
158. Kierkegaard A, Norgren L, Olsson CG, et al. Incidence of deep vein thrombosis in bedridden non-surgical patients. Acta Med Scand, 1987, 222(5): 409-414.
159. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2012, 141(2 Suppl): e227S-e277S.
160. Gee E. The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89). Br J Haematol, 2019, 186(5): 792-793.

Next Article
The methodological framework of surgical innovation: The interpretation of IDEAL reporting guideline

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Chinese guidelines for perioperative airway management in thoracic surgery (2020 edition)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content